Bisantrene Phase 2 AML Trial Successful Concludes
Released 29 Jul 24
Latest announcements
Ask a question
Your question will be sent privately to Race Oncology. The company may choose to make this question public.
Investor Q&As
Start the conversation
Ask Race Oncology a question about this announcement.